BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38228495)

  • 1. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.
    Zhou M; Yu H; Bai M; Lu S; Wang C; Ke S; Huang J; Li Z; Xu Y; Yin B; Li X; Feng Z; Fu Y; Jiang H; Ma Y
    Cancer Sci; 2024 Mar; 115(3):777-790. PubMed ID: 38228495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
    Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
    Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
    Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S
    J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.
    Zhou Z; Wang P; Sun R; Li J; Hu Z; Xin H; Luo C; Zhou J; Fan J; Zhou S
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
    Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells.
    Deng SK; Jin Y; Jin Y; Wang JF
    Neoplasma; 2022 Sep; 69(5):1101-1107. PubMed ID: 35951457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHH/GLI2-TGF-β1 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma.
    Chen Z; Li H; Li Z; Chen S; Huang X; Zheng Z; Qian X; Zhang L; Long G; Xie J; Wang Q; Pan W; Zhang D
    Pharmacol Res; 2023 Jan; 187():106564. PubMed ID: 36423790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
    Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
    Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma.
    Yang L; Han P; Cui T; Miao Y; Zhao T; Cui Z; Chen Y; Chi H; Zhang J; Zhang Y
    Front Immunol; 2023; 14():1251648. PubMed ID: 37809069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma.
    Wang C; Liang H; Li Y; Tang Z; Zhang Y
    Bioengineered; 2022 May; 13(5):12738-12748. PubMed ID: 35609322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
    Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression.
    Luo C; Xin H; Zhou Z; Hu Z; Sun R; Yao N; Sun Q; Borjigin U; Wu X; Fan J; Huang X; Zhou S; Zhou J
    Hepatology; 2022 Oct; 76(4):982-999. PubMed ID: 35106794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment.
    Lin Y; Li B; Yang X; Cai Q; Liu W; Tian M; Luo H; Yin W; Song Y; Shi Y; He R
    Neoplasia; 2019 Dec; 21(12):1133-1142. PubMed ID: 31759251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
    Sun BY; Yang ZF; Wang ZT; Liu G; Zhou C; Zhou J; Fan J; Gan W; Yi Y; Qiu SJ
    World J Surg Oncol; 2023 Mar; 21(1):90. PubMed ID: 36899373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.
    Yuan H; Lin Z; Liu Y; Jiang Y; Liu K; Tu M; Yao N; Qu C; Hong J
    Cancer Cell Int; 2020 Dec; 20(1):586. PubMed ID: 33372604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway.
    Yu W; Zeng F; Xiao Y; Chen L; Qu H; Hong J; Qu C; Cheng G
    Chem Biol Interact; 2024 Jan; 387():110816. PubMed ID: 38000456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3  phosphorylation and the MEK/ERK pathway.
    He Q; Pan X; Yin Y; Xu A; Yi X; Wu Y; Li X
    Parasit Vectors; 2023 Apr; 16(1):139. PubMed ID: 37095578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.